• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同激素受体表达的乳腺癌患者化疗引起的前瞻性记忆障碍

Chemotherapy-induced prospective memory impairment in breast cancer patients with different hormone receptor expression.

作者信息

Li Wen, Gan Chen, Lv Yue, Wang Shanghu, Cheng Huaidong

机构信息

Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

出版信息

Medicine (Baltimore). 2017 Mar;96(13):e6514. doi: 10.1097/MD.0000000000006514.

DOI:10.1097/MD.0000000000006514
PMID:28353608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5380292/
Abstract

This study aimed to investigate prospective memory impairment in patients with breast cancer with different expression of hormone receptors, including the estrogen receptor (ER) and the progesterone receptor (PR).A total of 120 patients with breast cancer who underwent chemotherapy following surgery were divided into 2 groups. The A group included 60 patients with ER/PR status, and the B group included 60 patients with ER/PR status. After 6 cycles of postoperative adjuvant chemotherapy, all patients were administered neuropsychological and prospective memory tests, such as the Mini-Mental State Examination (MMSE), verbal fluency test (VFT), and digit span test (DST), as well as examination of event-based prospective memory (EBPM) and time-based prospective memory (TBPM).As the neuropsychological background test results showed, there were no significant differences in MMSE, DST, and TBPM scores (*:P > 0.05) between patients with breast cancer in the ER/PR and ER/PR groups, while the VFT and EBPM scores were significantly greater in patients with breast cancer with ER/PR status than in those with ER/PR status (**: P < 0.01), indicating that patients with ER/PR status have significant impairment in EBPM, although not in TBPM.The results of the present study indicate that different hormone receptor expression in patients with breast cancer may be associated with heterogeneity of chemotherapy-induced prospective memory impairment.

摘要

本研究旨在调查激素受体(包括雌激素受体(ER)和孕激素受体(PR))表达不同的乳腺癌患者的前瞻性记忆损害情况。共有120例术后接受化疗的乳腺癌患者被分为2组。A组包括60例ER/PR状态的患者,B组包括60例ER/PR状态的患者。术后辅助化疗6个周期后,对所有患者进行神经心理学和前瞻性记忆测试,如简易精神状态检查表(MMSE)、语言流畅性测试(VFT)和数字广度测试(DST),以及基于事件的前瞻性记忆(EBPM)和基于时间的前瞻性记忆(TBPM)检查。神经心理学背景测试结果显示,ER/PR和ER/PR组的乳腺癌患者在MMSE、DST和TBPM评分上无显著差异(*:P>0.05),而ER/PR状态的乳腺癌患者的VFT和EBPM评分显著高于ER/PR状态的患者(**:P<0.01),表明ER/PR状态的患者在EBPM方面有显著损害,尽管在TBPM方面没有。本研究结果表明,乳腺癌患者不同的激素受体表达可能与化疗引起的前瞻性记忆损害的异质性有关。

相似文献

1
Chemotherapy-induced prospective memory impairment in breast cancer patients with different hormone receptor expression.不同激素受体表达的乳腺癌患者化疗引起的前瞻性记忆障碍
Medicine (Baltimore). 2017 Mar;96(13):e6514. doi: 10.1097/MD.0000000000006514.
2
Chemotherapy-induced prospective memory impairment in patients with breast cancer.乳腺癌患者化疗引起的前瞻性记忆障碍。
Psychooncology. 2013 Oct;22(10):2391-5. doi: 10.1002/pon.3291. Epub 2013 May 15.
3
Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.儿茶酚-O-甲基转移酶基因多态性与不同肿瘤激素受体表达的乳腺癌患者化疗诱导的前瞻性记忆损害风险
Med Sci Monit. 2020 Sep 28;26:e923567. doi: 10.12659/MSM.923567.
4
Prospective memory impairment following whole brain radiotherapy in patients with metastatic brain cancer.转移性脑癌患者全脑放疗后前瞻性记忆损伤。
Cancer Med. 2018 Oct;7(10):5315-5321. doi: 10.1002/cam4.1784. Epub 2018 Sep 27.
5
Impact of metastatic estrogen receptor and progesterone receptor status on survival.转移性雌激素受体和孕激素受体状态对生存的影响。
Breast Cancer Res Treat. 2005 Mar;90(1):65-70. doi: 10.1007/s10549-004-2756-z.
6
Event- and time-based prospective memory in hemodialysis patients.血液透析患者基于事件和时间的前瞻性记忆
Ren Fail. 2020 Nov;42(1):1135-1141. doi: 10.1080/0886022X.2020.1835673.
7
Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.新辅助剂量密集阿霉素、环磷酰胺序贯紫杉醇治疗乳腺癌时生物标志物ER、PR、HER 2和Ki-67变化的评估
J BUON. 2013 Jan-Mar;18(1):57-63.
8
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.使用定量氟-18氟脱氧葡萄糖/正电子发射断层扫描成像参数比较三阴性乳腺癌与雌激素受体阳性/孕激素受体阳性/人表皮生长因子受体2阴性乳腺癌:一种对疾病特征描述可能有用的方法。
Cancer. 2008 Mar 1;112(5):995-1000. doi: 10.1002/cncr.23226.
9
Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist.新辅助化疗对乳腺癌表型、雌激素受体/孕激素受体及人表皮生长因子受体2表达的影响——对肿瘤专科医生的启示
Eur J Cancer. 2016 Jun;60:40-8. doi: 10.1016/j.ejca.2016.03.006. Epub 2016 Apr 8.
10
A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer.I期和II期乳腺癌中类固醇激素受体的多因素分析。
Ann Surg. 1985 May;201(5):611-7. doi: 10.1097/00000658-198505000-00010.

引用本文的文献

1
Boron Containing Curcumin-Like Compound as an Acetylcholinesterase Inhibitor and Anticancer Agent: Synthesis, Biological Evaluation, and Computational Insights.含硼姜黄素类化合物作为乙酰胆碱酯酶抑制剂和抗癌剂:合成、生物学评价及计算分析
Cell Biochem Biophys. 2025 Sep 12. doi: 10.1007/s12013-025-01885-1.
2
Differences in cognitive deficits and brain functional impairments between patients with first-episode and recurrent depression.首发抑郁患者与复发性抑郁患者在认知缺陷和脑功能损害方面的差异。
BMC Psychiatry. 2025 Apr 29;25(1):434. doi: 10.1186/s12888-025-06758-8.
3
GSK3β rs3107669 polymorphism implicates chemotherapy-associated retrospective memory deficits in breast cancer survivors.GSK3β基因rs3107669多态性与乳腺癌幸存者化疗相关的回顾性记忆缺陷有关。
Am J Cancer Res. 2023 Oct 15;13(10):4961-4975. eCollection 2023.
4
A scoping review of cognitive assessment tools and domains for chemotherapy-induced cognitive impairments in cancer survivors.癌症幸存者化疗引起的认知障碍的认知评估工具和领域的范围综述。
Front Hum Neurosci. 2023 Feb 20;17:1063674. doi: 10.3389/fnhum.2023.1063674. eCollection 2023.
5
Sleep-dependent memory consolidation in breast cancer: Use of a virtual reality prospective memory task.乳腺癌中睡眠依赖的记忆巩固:虚拟现实前瞻性记忆任务的应用。
Front Neurosci. 2022 Sep 7;16:908268. doi: 10.3389/fnins.2022.908268. eCollection 2022.
6
COMT rs737865 mediates chemobrain in breast cancer patients with various levels of Ki-67.儿茶酚-O-甲基转移酶基因rs737865在不同Ki-67水平的乳腺癌患者中介导化疗脑。
Am J Cancer Res. 2022 Jul 15;12(7):3185-3197. eCollection 2022.
7
The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2-/+ Breast Cancer.儿茶酚-O-甲基转移酶基因因素调节HER2-/+乳腺癌幸存者中与化疗相关的前瞻性记忆损害。
Front Oncol. 2022 Feb 8;12:816923. doi: 10.3389/fonc.2022.816923. eCollection 2022.
8
Research advances on how metformin improves memory impairment in "chemobrain".二甲双胍改善“化疗脑”记忆障碍的研究进展
Neural Regen Res. 2022 Jan;17(1):15-19. doi: 10.4103/1673-5374.314284.
9
Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.儿茶酚-O-甲基转移酶基因多态性与不同肿瘤激素受体表达的乳腺癌患者化疗诱导的前瞻性记忆损害风险
Med Sci Monit. 2020 Sep 28;26:e923567. doi: 10.12659/MSM.923567.
10
Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer.乳腺癌患者化疗前后皮质脑龄变化。
Neurotox Res. 2020 Apr;37(4):788-799. doi: 10.1007/s12640-019-00158-z. Epub 2020 Jan 4.

本文引用的文献

1
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.脑源性神经营养因子基因多态性(rs6265)对早期乳腺癌患者化疗相关认知障碍具有保护作用。
Neuro Oncol. 2016 Feb;18(2):244-51. doi: 10.1093/neuonc/nov162. Epub 2015 Aug 19.
2
A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.一项关于多奈哌齐用于辅助化疗后1至5年自我报告有认知功能障碍的女性乳腺癌幸存者的研究。
J Cancer Surviv. 2016 Feb;10(1):176-84. doi: 10.1007/s11764-015-0463-x. Epub 2015 Jul 1.
3
Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females.中枢神经系统中的雌激素受体及其对雌性动物多巴胺依赖性认知的影响。
Horm Behav. 2015 Aug;74:125-38. doi: 10.1016/j.yhbeh.2015.06.010. Epub 2015 Jun 27.
4
[Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].[乳腺癌患者化疗相关认知障碍的患病率及特征]
J Korean Acad Nurs. 2015 Feb;45(1):118-28. doi: 10.4040/jkan.2015.45.1.118.
5
Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.成人非中枢神经系统癌症相关认知障碍的临床特征、病理生理学及管理
CA Cancer J Clin. 2015 Mar;65(2):123-38. doi: 10.3322/caac.21258. Epub 2014 Dec 5.
6
The experience of cognitive change in women with breast cancer following chemotherapy.乳腺癌女性化疗后认知变化的经历。
J Cancer Surviv. 2015 Sep;9(3):375-87. doi: 10.1007/s11764-014-0387-x. Epub 2014 Oct 25.
7
Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer's disease.雌激素受体α对阿尔茨海默病神经保护作用的最新进展。
J Alzheimers Dis. 2015;43(4):1137-48. doi: 10.3233/JAD-141875.
8
Triple-negative breast cancer in the post-genomic era.
Oncology (Williston Park). 2013 Sep;27(9):859-60, 864.
9
Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy.乳腺癌患者化疗结束1年后持续存在的认知变化。
J Int Neuropsychol Soc. 2014 Apr;20(4):370-9. doi: 10.1017/S1355617713001215. Epub 2013 Nov 15.
10
The Dynamic Multiprocess Framework: evidence from prospective memory with contextual variability.动态多重处理框架:来自具有上下文可变性的前瞻记忆的证据。
Cogn Psychol. 2013 Aug-Sep;67(1-2):55-71. doi: 10.1016/j.cogpsych.2013.07.001. Epub 2013 Aug 3.